CD19 and precursor B-cell acute lymphoblastic leukemia: The expression profile of cytokines have been investigated in B-ALL [22, 24], CLL [40], and diffuse large B-cell lymphoma (DLBCL) patients [25] treated with anti-CD19 CAR-T cell therapy, in an effort to identify predictive factors for CRS [24].